BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27022114)

  • 1. Strategies for Empiric Management of Pediatric Fever and Neutropenia in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review of Randomized Trials.
    Robinson PD; Lehrnbecher T; Phillips R; Dupuis LL; Sung L
    J Clin Oncol; 2016 Jun; 34(17):2054-60. PubMed ID: 27022114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.
    Lehrnbecher T; Robinson P; Fisher B; Alexander S; Ammann RA; Beauchemin M; Carlesse F; Groll AH; Haeusler GM; Santolaya M; Steinbach WJ; Castagnola E; Davis BL; Dupuis LL; Gaur AH; Tissing WJE; Zaoutis T; Phillips R; Sung L
    J Clin Oncol; 2017 Jun; 35(18):2082-2094. PubMed ID: 28459614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update.
    Lehrnbecher T; Robinson PD; Ammann RA; Fisher B; Patel P; Phillips R; Beauchemin MP; Carlesse F; Castagnola E; Davis BL; Elgarten CW; Groll AH; Haeusler GM; Koenig C; Santolaya ME; Tissing WJE; Wolf J; Alexander S; Hu H; Dupuis LL; Sung L
    J Clin Oncol; 2023 Mar; 41(9):1774-1785. PubMed ID: 36689694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of step-down to oral outpatient treatment versus inpatient antimicrobial treatment in pediatric cancer patients with febrile neutropenia: A noninferiority multicenter randomized clinical trial.
    Avilés-Robles MJ; Reyes-López A; Otero-Mendoza FJ; Valencia-Garin AU; Peñaloza-González JG; Rosales-Uribe RE; Muñoz-Hernández O; Garduño-Espinosa J; Juárez-Villegas L; Zapata-Tarrés M
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28251. PubMed ID: 32196898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: A systematic review of randomized trials.
    Egan G; Robinson PD; Martinez JPD; Alexander S; Ammann RA; Dupuis LL; Fisher BT; Lehrnbecher T; Phillips B; Cabral S; Tomlinson G; Sung L
    Cancer Med; 2019 Aug; 8(10):4536-4546. PubMed ID: 31274245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of antipseudomonal penicillins and cephalosporins in pediatric patients with fever and neutropenia.
    Manji A; Lehrnbecher T; Dupuis LL; Beyene J; Sung L
    Pediatr Infect Dis J; 2012 Apr; 31(4):353-8. PubMed ID: 22173145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review and meta-analysis of anti-pseudomonal penicillins and carbapenems in pediatric febrile neutropenia.
    Manji A; Lehrnbecher T; Dupuis LL; Beyene J; Sung L
    Support Care Cancer; 2012 Oct; 20(10):2295-304. PubMed ID: 22138849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children--a systematic review of prospective trials.
    Manji A; Beyene J; Dupuis LL; Phillips R; Lehrnbecher T; Sung L
    Support Care Cancer; 2012 Jun; 20(6):1135-45. PubMed ID: 22402749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial.
    Orme LM; Babl FE; Barnes C; Barnett P; Donath S; Ashley DM
    Pediatr Blood Cancer; 2014 Aug; 61(8):1427-33. PubMed ID: 24604835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
    Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
    Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenems versus alternative β-lactams monotherapy or in combination for febrile neutropenia: Systematic review and meta-analysis of randomized controlled trial.
    Tang X; Chen L; Li Y; Jiang J; Li X; Liang X
    Medicine (Baltimore); 2020 Oct; 99(43):e22725. PubMed ID: 33120768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia: A systematic review and Bayesian network meta-analysis.
    Tan X; Li Y; Xi J; Guo S; Su H; Chen X; Liang X
    Medicine (Baltimore); 2021 Dec; 100(50):e27266. PubMed ID: 34918626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.
    Jing Y; Li J; Yuan L; Zhao X; Wang Q; Yu L; Zhou D; Huang W
    Clin Transplant; 2016 Mar; 30(3):263-9. PubMed ID: 26701371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of cefozopran versus cefepime as empirical antibiotic treatment of febrile neutropenia in pediatric cancer patients.
    Sarashina T; Kobayashi R; Yoshida M; Toriumi N; Suzuki D; Sano H; Azuma H
    Pediatr Blood Cancer; 2014 Nov; 61(11):1992-5. PubMed ID: 25130289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting.
    Kaya AH; Tekgündüz E; Duygu F; Koca D; Bekdemir F; Batgi H; Ulu Uncu B; Yiğenoğlu TN; Dal MS; Çakar Kızıl M; Altuntaş F
    Balkan Med J; 2017 Apr; 34(2):132-139. PubMed ID: 28418340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolones in children with fever and neutropenia: a systematic review of prospective trials.
    Sung L; Manji A; Beyene J; Dupuis LL; Alexander S; Phillips R; Lehrnbecher T
    Pediatr Infect Dis J; 2012 May; 31(5):431-5. PubMed ID: 22189521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis.
    Teuffel O; Ethier MC; Alibhai SMH; Beyene J; Sung L
    Ann Oncol; 2011 Nov; 22(11):2358-2365. PubMed ID: 21363878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia.
    Rearigh L; Stohs E; Freifeld A; Zimmer A
    Ann Hematol; 2020 Aug; 99(8):1917-1924. PubMed ID: 32556455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients.
    Kamonrattana R; Sathitsamitphong L; Choeyprasert W; Charoenkwan P; Natesirinilkul R; Fanhchaksai K
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2733-2737. PubMed ID: 31554370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.